https://us.eisai.com/ 2025-10-29 daily 0.5 https://us.eisai.com/mediadownload 2025-07-24 daily 0.5 https://us.eisai.com/search 2025-05-28 daily 0.5 https://us.eisai.com/privacy-policy 2025-07-18 daily 0.5 https://us.eisai.com/who-we-are 2025-08-12 daily 0.5 https://us.eisai.com/our-science 2025-11-10 daily 0.5 https://us.eisai.com/our-medicines 2025-12-09 daily 0.5 https://us.eisai.com/our-patient-focus 2026-01-20 daily 0.5 https://us.eisai.com/uk-privacy-policy 2025-07-18 daily 0.5 https://us.eisai.com/legal-notices 2025-07-18 daily 0.5 https://us.eisai.com/social-media-guidelines 2025-06-20 daily 0.5 https://us.eisai.com/contact-us 2025-06-20 daily 0.5 https://us.eisai.com/site-map 2025-06-25 daily 0.5 https://us.eisai.com/media-center 2025-10-27 daily 0.5 https://us.eisai.com/privacy-policy/your-choices-and-rights 2025-07-18 daily 0.5 https://us.eisai.com/privacy-policy/california-privacy-supplement 2025-08-12 daily 0.5 https://us.eisai.com/privacy-policy/health-data-privacy-policy-supplement 2025-08-07 daily 0.5 https://us.eisai.com/who-we-are/eisai-in-the-us 2025-11-19 daily 0.5 https://us.eisai.com/who-we-are/human-health-care-mission 2025-07-04 daily 0.5 https://us.eisai.com/who-we-are/our-locations 2026-01-06 daily 0.5 https://us.eisai.com/who-we-are/corporate-responsibility 2025-07-04 daily 0.5 https://us.eisai.com/who-we-are/leadership 2026-02-02 daily 0.5 https://us.eisai.com/who-we-are/awards-and-recognition 2025-07-18 daily 0.5 https://us.eisai.com/who-we-are/history-of-eisai 2025-07-04 daily 0.5 https://us.eisai.com/who-we-are/collaboration 2025-08-12 daily 0.5 https://us.eisai.com/our-science/global-pipeline 2025-11-10 daily 0.5 https://us.eisai.com/our-science/disease-areas 2026-01-20 daily 0.5 https://us.eisai.com/our-science/clinical-trials 2025-08-07 daily 0.5 https://us.eisai.com/our-science/g2d2 2025-09-25 daily 0.5 https://us.eisai.com/our-medicines/our-products 2025-11-19 daily 0.5 https://us.eisai.com/our-medicines/manufacturing 2025-07-18 daily 0.5 https://us.eisai.com/our-medicines/eisai-medical-information 2025-07-17 daily 0.5 https://us.eisai.com/our-medicines/pharmacy-trade-relations 2025-07-18 daily 0.5 https://us.eisai.com/our-patient-focus/community-involvement 2026-01-20 daily 0.5 https://us.eisai.com/our-patient-focus/magnolia-patient-support-programs 2025-07-23 daily 0.5 https://us.eisai.com/our-patient-focus/eisai-usa-foundation 2025-07-18 daily 0.5 https://us.eisai.com/our-patient-focus/eisai-grants-programs 2025-07-18 daily 0.5 https://us.eisai.com/media-center/digital-asset-library 2025-07-25 always https://us.eisai.com/media-center/media-search 2025-07-07 daily 0.5 https://us.eisai.com/who-we-are/corporate-responsibility/corporate-compliance-program 2025-08-12 daily 0.5 https://us.eisai.com/who-we-are/corporate-responsibility/interacting-with-hcps 2025-08-07 daily 0.5 https://us.eisai.com/who-we-are/collaboration/business 2025-08-13 daily 0.5 https://us.eisai.com/who-we-are/collaboration/advocacy-support 2025-07-04 daily 0.5 https://us.eisai.com/who-we-are/collaboration/research-collaboration 2025-08-13 daily 0.5 https://us.eisai.com/who-we-are/collaboration/startups 2025-07-04 daily 0.5 https://us.eisai.com/our-science/disease-areas/oncology 2025-08-07 daily 0.5 https://us.eisai.com/our-science/disease-areas/neurology 2026-01-20 daily 0.5 https://us.eisai.com/our-science/clinical-trials/access-to-investigational-drugs 2025-08-12 daily 0.5 https://us.eisai.com/our-science/clinical-trials/improving-access 2025-08-12 daily 0.5 https://us.eisai.com/our-science/g2d2/g2d2-approach 2025-07-17 daily 0.5 https://us.eisai.com/our-science/g2d2/g2d2-facility 2025-07-17 daily 0.5 https://us.eisai.com/our-science/g2d2/g2d2-human-health-care-mission 2025-07-17 daily 0.5 https://us.eisai.com/our-patient-focus/community-involvement/oncology 2026-03-04 daily 0.5 https://us.eisai.com/our-patient-focus/community-involvement/neurology 2026-03-04 daily 0.5 https://us.eisai.com/who-we-are/corporate-responsibility/interacting-with-hcps/payments-to-physicians 2025-08-12 daily 0.5 https://us.eisai.com/who-we-are/corporate-responsibility/interacting-with-hcps/state-pricing-disclosures 2025-08-13 daily 0.5 https://us.eisai.com/our-science/disease-areas/oncology/cancers-of-focus 2025-07-18 daily 0.5 https://us.eisai.com/our-science/disease-areas/oncology/visualizing-empathy 2025-07-18 daily 0.5 https://us.eisai.com/our-science/disease-areas/neurology/addementia 2026-03-03 daily 0.5 https://us.eisai.com/our-science/disease-areas/neurology/sleep-wake-disorders 2025-07-18 daily 0.5 /press-releases/122930 2025-08-12 daily 0.5 /press-releases/eisai-named-to-list-of-the-time-100-most-influential-companies 2025-07-09 daily 0.5 /press-releases/leqembi-lecanemab-approved-for-the-treatment-of-alzheimers-disease-in-hong-kong 2025-07-09 daily 0.5 /press-releases/leqembi-lecanemab-approved-for-the-treatment-of-alzheimers-disease-in-israel 2025-07-09 daily 0.5 /press-releases/leqembi-lecanemab-approved-for-the-treatment-of-alzheimers-disease-in-south-korea 2025-07-09 daily 0.5 /press-releases/leqembi-lecanemab-for-the-treatment-of-alzheimers-disease-launched-in-china 2025-07-09 daily 0.5 /press-releases/update-on-regulatory-review-of-lecanemab-for-early-alzheimers-disease-in-the-european-union 2025-07-08 daily 0.5 /press-releases/eisai-receives-regulatory-review-outcome-for-lecanemab-as-a-treatment-for-early-alzheimers-disease-in-australia 2025-07-09 daily 0.5 /press-releases/eisai-to-present-the-latest-research-results-including-long-term-and-real-world-data-on-lecanemab-and-biomarkers-for-alzheimers-disease-at-the-adpd-2025-annual-meeting 2025-08-13 daily 0.5 /press-releases/update-on-regulatory-review-of-lecanemab-for-early-alzheimers-disease-by-the-european-commission 2025-07-09 daily 0.5 /press-releases/04-14-2025-update-on-regulatory-review-of-lecanemab-for-early-alzheimers-disease-by-the-european-commission 2025-06-26 daily 0.5 /press-releases/leqembi-lecanemab-is-the-first-medicine-that-slows-progression-of-early-alzheimers-disease-to-be-authorized-in-the-european-union 2025-06-19 daily 0.5 /press-releases/medtech-breakthrough-recognizes-eisai-biogen-and-medisafe-for-alzheimers-disease-treatment-innovation 2025-06-26 daily 0.5 /press-releases/favorable-decision-in-patent-litigation-related-to-lenvatinib 2025-06-19 daily 0.5 /press-releases/leqembi-lecanemab-approved-for-slowing-the-progression-of-early-alzheimers-disease-in-singapore 2025-08-13 daily 0.5 /press-releases/new-drug-approval-for-in-house-developed-anti-insomnia-drug-dayvigo-lemborexant-in-china 2025-07-09 daily 0.5 /press-releases/fda-approves-leqembi-iqlik-ovveride 2025-09-02 daily 0.5 /press-releases/leqembi-lecanemab-approved-for-the-treatment-of-alzheimers-disease-in-australia 2025-09-24 daily 0.5 /press-releases/notice-of-the-settlement-of-patent-infringement-litigation-related-to-lenvatinib-in-the-us 2025-09-24 daily 0.5 /press-releases/leqembi-lecanemab-iv-maintenance-dosing-for-the-treatment-of-early-alzheimers-disease-approved-in-china 2025-09-29 daily 0.5 /press-releases/health-canada-grants-authorization-for-leqembi-lecanemab-for-the-treatment-of-early-alzheimers-disease 2025-10-27 daily 0.5 /press-releases/leqembi-lecanemab-iv-maintenance-dosing-for-the-treatment-of-early-alzheimers-disease-approved-in-the-united-kingdom 2025-11-13 daily 0.5 /press-releases/eisai-submits-new-drug-application-for-subcutaneous-formulation-of-leqembi-for-the-treatment-of-early-alzheimers-disease-in-japan 2025-11-26 daily 0.5 /press-releases/eisai-celebrates-new-state-of-the-art-manufacturing-facility-in-baltimore 2026-01-05 daily 0.5 /press-releases/biologics-license-application-for-subcutaneous-formulation-of-leqembi-lecanemab-for-the-treatment-of-early-alzheimers-disease-accepted-in-china 2026-01-06 daily 0.5 /press-releases/welireg-belzutifan-plus-lenvima-lenvatinib-reduced-the-risk-of-disease-progression-or-death-by-30-compared-to-cabozantinib-in-certain-previously-treated-patients-with-advanced-renal-ce 2026-02-28 daily 0.5 /articles/the-turning-point-for-alzheimers-disease 2025-07-03 always /articles/ad-disease-progression 2025-07-03 daily 0.5 /articles/ad-risk-factors 2025-07-03 daily 0.5 /articles/expert-perspectives-new-paradigms-of-cancer-care-and-the-evolving-role-of-telemedicine 2025-07-24 always /articles/linkedin-live-ad-panel 2025-07-02 daily 0.5 /articles/pathology-of-ad 2025-11-10 daily 0.5 /articles/symptom-awareness-in-ad 2025-07-24 daily 0.5 /articles/urgent-need-for-a-patient-centered-care 2025-07-24 daily 0.5 /articles/alzheimers-disease-innovation-prioritizing-patients 2025-07-02 always /articles/biomarkers-research-early-diagnosis-alzheimers 2025-07-02 always /articles/contributor-coping-with-insomnia-during-covid19 2025-07-03 always /articles/digital-opinion-leader-video-podcast-how-social-media-is-breaking-silos-in-the-oncology-community 2025-07-03 always /articles/eisai-and-merck-team-up-to-help-fight-cancer 2025-08-12 always /articles/eisai-publishes-potential-economic-value-of-investigational-lecanemab 2025-07-02 always /articles/going-deep-human-to-find-the-next-oncology-game-changer 2025-07-09 always /articles/higher-health-care-resource-use-costs-associated-with-falls-among-older-medicare-beneficiaries 2025-07-02 always /articles/link-between-number-of-falls-with-annual-incidence-of-having-at-least-one-fall 2025-07-03 always /articles/looking-towards-an-integrated-oncology-future 2025-07-03 always /articles/understanding-alzheimers-disease-community-needs 2025-07-09 always /articles/why-holistic-treatments-for-insomnia-are-becoming-more-popular 2025-07-03 always /articles/experts-discuss-assessing-meaningful-benefits-in-early-alzheimers-disease-ad 2025-07-24 daily 0.5 /blogs/addressing-the-unmet-needs-of-us-veterans-through-equine-assisted-therapy 2025-07-07 always /blogs/applying-our-in-field-expertise-in-a-new-virtual-world 2025-06-24 always /blogs/continuing-our-commitment-to-health-by-contributing-to-a-more-sustainable-world 2025-06-25 always /blogs/eisais-nurses-reflect-on-their-profession-and-the-nightingale-legacy 2025-06-26 always /blogs/eisai-utilizes-extrapolation-a-regulatory-pathway-to-provide-epilepsy-patients 2025-06-26 always /blogs/four-ways-the-medical-affairs-industry-has-adapted-to-optimize-socially-distanced-engagements 2025-06-24 always /blogs/life-at-eisai-building-a-culture-of-collaboration-and-innovation 2025-06-26 always /blogs/making-a-sustainable-impact-in-the-community-and-around-the-world 2025-07-22 always /blogs/natures-gift-to-medicines-discovery 2025-06-24 always /blogs/oncologist-perspective-world-cancer-day 2025-06-24 always /blogs/prioritizing-sleep-health-while-adjusting-to-daylight-saving-time 2025-07-22 always /blogs/real-world-data-in-real-time-transforming-patient-data-to-improve-public-health-outcomes 2025-06-24 always /blogs/responseability-a-new-response-to-cancer-therapy-in-an-era-of-improved-patient-outcomes 2025-06-24 always /blogs/sparking-change-for-people-living-with-breast-and-ovarian-cancer 2025-06-24 always /blogs/spotlighting-what-makes-eisai-oncology-unique-this-world-cancer-day 2025-06-24 always /blogs/the-atxn-classification-system-and-its-potential-use-in-clinical-practice-and-therapy-development 2025-07-22 always /blogs/the-relentless-pursuit-of-a-world-without-cancer 2025-06-26 always /blogs/three-critical-questions-medical-affairs-professionals-are-asking-in-todays-world 2025-06-24 always /blogs/times-may-change-but-the-need-for-medical-education-only-grows-stronger 2025-06-24 always /blogs/working-to-address-unmet-needs-in-womens-cancers 2025-06-26 always /blogs/podcast-episode-1-understanding-the-disease 2025-06-24 always /blogs/podcast-episode-2-risk-factors 2025-06-24 always /blogs/podcast-episode-3-early-symptoms 2025-06-24 always /blogs/podcast-episode-4-diagnosis 2025-06-24 always /blogs/podcast-episode-5-care-partner 2025-06-24 always /blogs/podcast-episode-6-future-of-diagnosis-and-treatment 2025-06-24 always /blogs/empowering-leaders-during-women-history-month 2025-06-25 always /blogs/esmo-2020-where-innovation-meets-human-health-care 2025-06-27 always /blogs/inspiring-young-women-career-in-stem 2025-07-08 always /blogs/understanding-and-supporting-kidney-cancer 2025-06-24 always /blogs/collaboration-between-medical-affairs-and-clinical-teams-to-advance-patient-care 2025-07-04 always /blogs/understanding-the-progressive-nature-of-alzheimers-disease-and-long-term-considerations 2025-07-09 always /blogs/leadership-perspective-innovation-and-cooperation-in-alzheimers-disease 2025-06-23 always /blogs/2025-national-cancer-survivors-month 2025-06-25 always /blogs/what-does-responsible-ai-look-like-in-health-care 2026-03-12 always